14158 Results (Page 463 of 567)
All Market Research Reports
Hong Kong Physiotherapy Market Analysis
The Hong Kong physiotherapy market size was valued at $77 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.85% from 2022 to 2030 and will reach $145 Mn in 2030. Hong Kong's physiotherapy market is expected to grow due to, increasing geriatric population, increasing chronic conditions such as obesity and diabetes. The market is segmented by Product Type, Application Type, and End User. The major players in the Hong Kong physiotherapy market are SBM Medical Equipment Company, Hong Kong Medix Co. Ltd, Hong Kong Medical and Biotech Industries Association (HKMBIA) and others.
APAC Physiotherapy Market Analysis
The APAC physiotherapy market size was valued at $11.17 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.12% from 2022 to 2030 and will reach $19.36 Bn in 2030. APAC's physiotherapy market is expected to grow due to several factors, a growing focus on preventative care, including an aging population, and an increase in chronic diseases. The market is segmented by Product Type, Application Type, and End User. The major players in the APAC physiotherapy market are PhysioGlobal, BTL, EMS Physio Ltd., Dynatronics Corporation, RICHMAR, and others.
Japan Bioinformatics Market Analysis
The Japan Bioinformatics market is projected to grow from $0.95 Bn in 2022 to $3.31 Bn by 2030, registering a CAGR of 16.8% during the forecast period of 2022 - 2030. The main factors driving the growth are rising government funding, an increase in genomics and proteomics research projects, and a developed healthcare system. The market is segmented by technology and by application. Some of the major players include Fujitsu (JPN), NEC (JPN), M3 (JPN), IBM Life Sciences, BioWisdom Ltd.
India Bioinformatics Market Analysis
The India Bioinformatics market is projected to grow from $0.28 Bn in 2022 to $1.15 Bn by 2030, registering a CAGR of 19.30% during the forecast period of 2022 - 2030. The main factors driving the growth would be collaborations with other countries and growth in the biotechnology market. The market is segmented by technology and by application. Some of the major players include Strand Life Science (IND), Ocimum Biosolutions (IND), Genotypic Technology (IND), Agilent Technologies, and Life Technologies Corporation.
China Bioinformatics Market Analysis
The China Bioinformatics market is projected to grow from $1.23 Bn in 2022 to $4.58 Bn by 2030, registering a CAGR of 17.80% during the forecast period of 2022 - 2030. The main factors driving the growth are technological advancements and government support. The market is segmented by technology and by application. Some of the major players include BGI Group (CHN), Novogene (CHN), Wuxi NextCODE (CHN), Illumina Inc., Agilent Technologies.
US Bioinformatics Market Analysis
The US Bioinformatics market is projected to grow from $6.447 Bn in 2022 to $18.781 Bn by 2030, registering a CAGR of 14.30% during the forecast period of 2022 - 2030. The main factors driving the growth would be the increased adoption of precision medicine, the growing use of genomics in drug discovery, technological advancements, and the rising volume of biological data created. The market is segmented by technology and by application. Some of the major players include Biovia (USA), IBM Life Sciences (USA), 3rd Millennium Inc (USA), Celera Corporation (USA), Illumina Inc. (USA), Agilent Technologies (USA), Affymetrix (USA), BioWisdom Ltd.
US Breast Cancer Therapeutics Market Analysis
The US breast cancer therapeutics market size is projected to grow to $ 17.48 Bn by 2030 from $7.64 Bn in 2022, exhibiting a CAGR of 10.9% during the forecast period (2022-2030), according to the study conducted by Insights10. A lifetime diagnosis of invasive breast cancer is estimated to occur in 13% of women (1 in 8), and 3% (1 in 39) are prone to mortality, according to the American Cancer Society (US) Statistics 2020. Newer interventions in the competitive landscape are estimated to reach $4.6 Bn in revenues from major players like AstraZeneca, and Daiichii Sankyo thanks to the sizeable market demands.
Japan Breast Cancer Therapeutics Market Analysis
The Japan breast cancer therapeutics market is expected to witness growth from $1.13 Bn in 2022 with a CAGR of 13.4% for the forecasted year 2022-2030 to $3.09 Bn in 2030 due to growth drivers like the increasing incidence of breast cancer and awareness programs in Japan. The breast cancer therapeutics market is segmented by therapy, by cancer type, and by distribution channel. Major players in Japan breast cancer therapeutics market include Takeda Pharmaceutical Co. Ltd., Eisai Co., Ltd, AstraZeneca PLC.
India Breast Cancer Therapeutics Market Analysis
The India breast cancer therapeutics market is witnessing a boost from $331 Mn in 2022 to $1,078 Mn in 2030 with a CAGR of 15.9% for the period 2022-2030 mainly due to increased incidence of breast cancer and novel treatment advances. The market is segmented by therapy, by cancer type and by distribution channel. Key players like Sun Pharmaceutical Industries, AbbVie Inc., and Amgen Inc. are leading companies in the breast cancer therapeutics market.
China Breast Cancer Therapeutics Market Analysis
With rising incidences of breast cancer and new technological advancements in breast cancer therapeutics, the China breast cancer therapeutics market is projected to expand from $1.46 Bn in 2022 with a CAGR of 14.4% for the year 2022-2030 to $4.29 Bn in 2030. The China breast cancer market is segmented by therapy, cancer type, and by distribution channel. Shenzhen Main Luck Pharmaceuticals Inc., Bristol-Myers Squibb Co., Eli Lilly, and Co. are some of the key players in the market.
Canada Breast Cancer Therapeutics Market Analysis
The Canada breast cancer therapeutics market size is valued at $1.45 Bn in 2022 and is estimated to expand at a compound annual growth rate of 12.9% from 2022 to 2030 and will reach $3.84 Bn in 2030 and this rise is attributed to the novel therapies for curing breast cancer and increasing research and development activities in Canada. The market is segmented by therapy, by cancer type and by distribution channel. Some of the leading companies in the market are Johnson & Johnson Services Inc., Pfizer Inc., AbbVie Inc., etc.
UK Oncology Drugs Market Analysis
By 2030, it is anticipated that the UK oncology drugs market will reach a value of $10.6 Bn from $5.1 Bn in 2022, growing at a CAGR of 9.6% during 2022-2030. The companies operating in the oncology drug in the UK market are Immunocore, Adaptimmune, and Oxford BioMedica. The UK oncology drugs market is segmented on the basis of therapy modality and types of cancer. The market is influenced by the National Health Service (NHS) which is responsible for the majority of cancer drug spending in the UK.
Australia Oncology Drugs Market Analysis
By 2030, it is anticipated that the Australia oncology drugs market will reach a value of $6.3 Bn from $2.36 Bn in 2022, growing at a CAGR of 13.1% during 2022-2030. The companies operating in the oncology drug in Australia market are Bristol Myers Squibb, Aucentra Therapeutics, and Natco Pharma. The Australia oncology drugs market is segmented on the basis of therapy modality and types of cancer. Factors such as increased awareness about cancer and its treatments and taxation policies by the government are some of the major drivers of growth in the Australian oncology drug market.
France Digital Health Market Analysis
The France Digital Health market is projected to grow from $ 5.8Bn in 2022 to $ 21.23Bn by 2030, registering a CAGR of 17.6% during the forecast period of 2022 - 2030. The market seems to be driven by supportive government policies, private digital health investments, and growing demands of the same. The market is segmented by solution, by deployment & by end-use. Some of the major players include Doctolib, Owkin & Meditech.
China ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
The China ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $2.376 Bn in 2022 to $3.702 Bn by 2030, registering a CAGR of 5.70% during the forecast period of 2022 - 2030. The number of individuals diagnosed with ADHD is on the rise in China, leading to a higher demand for ADHD medications. Some of the key players in the China ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market include Novartis, Pfizer, Shire (now part of Takeda), CSPC Pharmaceutical Group, Lanzhou Institute of Biological Products, Huadong Medicine, Hainan Zhongxin Pharmaceutical, Jiangsu Hengrui Medicine, Hunan Erkang Pharmaceutical, Tiantai Pharmaceutical.
India ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
The India ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $538 Mn in 2022 to $938 Mn by 2030, registering a CAGR of 7.20% during the forecast period of 2022 - 2030. The number of individuals diagnosed with ADHD is on the rise in India, leading to a higher demand for ADHD medications. Some key players in the India ADHD drugs market include Sun Pharmaceutical Industries, Cipla, Glenmark Pharmaceuticals, Lupin Limited, and Torrent Pharmaceuticals. These companies offer a variety of ADHD medications and have a significant presence in the Indian market. However, it is worth noting that there are many other companies operating in this market as well.
Germany ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
The Germany ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $1.082 Bn in 2022 to $1.308 Bn by 2030, registering a CAGR of 2.40% during the forecast period of 2022 - 2030. The German government plays a significant role in the market through its reimbursement policies and regulations, which can affect the pricing and availability of drugs. One of the major players in the German ADHD drugs market is Novartis. Novartis is one of the leading pharmaceutical companies in Germany, and it offers a variety of ADHD drugs, including Ritalin and Concerta.
Japan Physiotherapy Market Analysis
The Japan physiotherapy market size was valued at $3.3 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.35% from 2022 to 2030 and will reach $5.4 Bn in 2030. Japan physiotherapy market is expected to grow due to, an aging population, an increase in chronic diseases, and a growing focus on preventative care.The market is segmented by Product Type, Application Type, and End User. The major players in the Japan physiotherapy market are Nihon Kohden, Fysio-Therapy, S&S Co., Ltd., Fujirebio, Takeda Medical and others
US Physiotherapy Market Analysis
The US physiotherapy market size was valued at $22.34Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 3.85% from 2022 to 2030 and will reach $30.22Bn in 2030. The physiotherapy market in US is expected to see steady growth in the coming years, as an aging population, an increase in chronic diseases, greater focus on preventative care and rehabilitation after surgeries. The market is segmented by Product Type, Application Type, and End User. The major players in the US physiotherapy market are BTL Industries, EMS Physio Ltd., DJO Global, Inc., Dynatronics Corporation, Inc., Performance Health, and others.
Italy Physiotherapy Market Analysis
The Italy physiotherapy market size was valued at $1.27 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.35% from 2022 to 2030 and will reach $1.93 Bn in 2030. Italy physiotherapy market is expected to grow due to, an increase in chronic diseases, an aging population, and a growing focus on preventative care. The market is segmented by Product Type, Application Type and End User. The major players in the Italy physiotherapy market are Tecno-Gaz, Tecno-Med, Medel, Alfa Medical, Elleci Medical Equipment, and others.
Spain Physiotherapy Market Analysis
The Spain physiotherapy market size was valued at $1.02 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.35% from 2022 to 2030 and will reach $1.5 Bn in 2030. Spain physiotherapy market is expected to grow due to, an increase in chronic diseases, an aging population, and a growing awareness on physiotherapy. The market is segmented by Product Type, Application Type and End User. The major players in the Spain physiotherapy market Fisio Equipment, Fisioterapia-movil, Fisio-line, Physiomed and others.
China Physiotherapy Market Analysis
The China physiotherapy market size was valued at $4.2 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.35% from 2022 to 2030 and will reach $7.5 Bn in 2030. China physiotherapy market is expected to grow due to several factors, including an aging population, an increase in chronic diseases, and a growing focus on preventative care. The market is segmented by Product Type, Application Type, and End User. The major players in the China physiotherapy market are Mindray Medical International, A. Menarini Diagnostics, Suzhou Acmed Import and Export Co., Shanghai Fosun Long March Medical Science Co, Beijing Choice Electronic Technology Co., Shenzhen Med-Link Electronics Tech Co., and others
Germany Digital Health Market Analysis
The Germany digital health market is projected to grow from $7.72 Bn in 2022 to $26.75 Bn by 2030, registering a CAGR of 16.8% during the forecast period of 2022 - 2030. The major drivers of the market include a higher healthcare spending capacity in Germany and government initiatives in order to promote the growth of the same. The market is segmented by solution, by deployment & by end-use. Some of the major players include Siemens Healthineers, Celesio AG & Allianz SE.
UK Dermatology Drugs Market Analysis
The UK dermatology drugs Market is projected to grow from $442 Mn in 2022 to $868 Mn by 2030, registering a CAGR of 8.8% during the forecast period of 2022-2030. The UK dermatology drugs market is segmented by disease, drug class, and route of administration. A number of factors, such as the increasing prevalence of skin conditions, the rising demand for cosmetic procedures in the UK, and the availability of novel and cutting-edge therapies, are driving the market. The leading businesses in the UK dermatology drugs Market include Unilever and Sanofi, to name a few.
China Oncology Drugs Market Analysis
The China oncology drugs market size was valued at $15.79 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 13.1% from 2022 to 2030 and will reach $42.28 Bn in 2030. The China oncology drug market is segmented by disease, drug type, and end user. The factors driving the oncology drugs market in China are the increasing interest of people in partnerships and trends of research in drugs. A few key players in the oncology drugs market in China are Bio-Thera, I-Mab, Beigene, and Alphamab.
